Navigation Links
Genomic Health Announces Year-End 2010 Financial Results, Provides 2011 Financial Outlook
Date:2/8/2011

ogo, Oncotype, Oncotype DX and Recurrence Score are trademarks or registered trademarks of Genomic Health, Inc. All other trademarks and service marks are the property of their respective owners.Genomic Health, Inc.Condensed Consolidated Statements of Operations (in thousands, except per share amounts)For the Three Months Ended For the Twelve Months Ended December 31,December 31,2010

20092010

2009(Unaudited)(Unaudited)REVENUES:Product revenues

$
46,317

$
39,053$
74,870

$
46,581Contract revenues

799

5303,231

2,967Total revenues

47,116

39,583178,101

149,548OPERATING EXPENSES:Cost of product revenues

8,707

8,54234,634

32,562Research and development

9,272

8,68433,225

35,691Selling and marketing

18,536

15,41471,405

61,132General and administrative

9,278

7,24634,913

29,564Total operating expenses

45,793

39,886174,177

158,949Income (loss) from operations

1,323

(303)3,924

(9,401)Interest and other income

58

79277

670Interest and other expense

18

1149

120Income (loss) before income taxes

1,363

(235)4,152

(8,851)Income tax provision (benefit)

(322)

106(136)

560Net income (loss)

$
,685

$
(341)$
4,288

$
(9,411)Basic net income (loss) per share

$
.06

$
(0.01)$
.15

$
(0.33)Diluted net income (loss) per share

$
.06

$
(0.01)$
.14

$
(0.33)Shares used to compute basic net income (loss) per share

28,910

28,63628,815

28,563Shares used to compute diluted net income (loss) per share

29,763

28,63629,653

28,563Genomic Health, Inc.Condensed Consolidated Balance Sheets(in thousands)As of

As ofDecember 31, 2010

Dece
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  ResMed (NYSE: ... signed a definitive agreement to acquire Curative ... ventilation and sleep-disordered breathing medical devices and ... market reputation in China, combined with ResMed,s global leadership in sleep and ... China suffering from ...
(Date:7/30/2015)... 30, 2015  EP Global Communications, Inc. (Public OTC: ... contacted the Company about discussing EPGL,s electronic contact ... Monday, August 3, 2015.  Novartis CEO Joe ... the coming electronic contact lens market could be ... next several years.  Novartis partnered with Google in ...
(Date:7/30/2015)... Calif., July 30, 2015  Amgen (NASDAQ: ... second quarter of 2015. Key results include: ... second quarter of 2014 to $5,370 million, with ... Enbrel ® (etanercept), Prolia ® (denosumab), ... and XGEVA ® (denosumab). Unfavorable changes in ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... Dong-A PharmTech Co. Ltd., announced that its ... III trials for udenafil, a new long acting drug ... double-blind, placebo-controlled trial is designed to evaluate the safety ... of phosphodiesterase versus placebo. The trials will be ...
... Nov. 4 CVS Caremark (NYSE: CVS ) ... position of SVP, Marketing for its pharmacy benefit management ... marketing from Jack Bruner, who is transitioning to the ... http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO ) , Greer brings ...
Cached Medicine Technology:Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development 2Company Appoints New SVP, Marketing for PBM Business 2
(Date:7/31/2015)... Santa Clara, CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 ... The National Football League’s biggest day each year is the Super Bowl. In the ... buildup that takes place from the host venue. The 2016 Super Bowl game will mark ...
(Date:7/31/2015)... ... July 31, 2015 , ... Last week, the ... The store can be accessed by visiting http://www.curemeso.org/store . , “Our new ... The best part: whenever a product is purchased, the Meso Foundation receives a ...
(Date:7/31/2015)... ... 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, Lakeview ... The medical community, social workers, law enforcement, and government officials are all invited ... effort to better understand and combat sex trafficking. Lead by sex trafficking expert ...
(Date:7/31/2015)... York, NY (PRWEB) , ... July 31, 2015 , ... ... Rodgers Theatre . Those looking to catch a new and refreshing show on ... won numerous awards and achievements including an Obie Award, Outer Critics Circle Award, Drama ...
(Date:7/31/2015)... (PRWEB) , ... July 31, ... ... Jason T. Brown’s live lecture on pharmaceutical negligence is now available online ... was well received with a 94% approval rating from the nationwide audience. ...
Breaking Medicine News(10 mins):Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2
... Program increases community access to automated external defibrillators , ... more lives from sudden cardiac arrest (SCA), The Richard B. ... Washington University will launch the ReStart DC program on ... to place automated external defibrillators (AEDs) where large numbers of ...
... LAKE CITY, June 11 Clinical Innovations has launched ... clinicians provide precise, consistent and reliable circumcision outcomes. Touted ... past 50 years, the AccuCirc utilizes revolutionary technology to ... precise cut of the foreskin in a single actuation. ...
... LIVERPOOL, England, June 11 ... nutrition, announces the launch of Neocate Nutra,the first ... amino acids.,Neocate Nutra has been specifically developed for ... allergy (CMPA) and multiple food protein,intolerance (MFPI). Unlike ...
... 11 A call for participants has been ... certification for medical interpreters. The National Board of ... independent 501(c)3 non-profit certification entity, will oversee the ... the certification process is credible, transparent, valid and ...
... June 11 Apollo Health Street, the nation,s ... and implementation services to healthcare ISVs, announced today ... Record application developed for one of its clients. ... Commission for Healthcare Information Technology (CCHIT) for its ...
... MDS Inc. (TSX: MDS; NYSE: MDZ ), a ... sciences markets, today reported financial results for the three-month period ... total revenue of $282 million, a net loss of $17 ... second quarter of 2009. These results include a non-cash asset ...
Cached Medicine News:Health News:ReStart DC Launches Life-Saving Public Access Defibrillation Program 2Health News:ReStart DC Launches Life-Saving Public Access Defibrillation Program 3Health News:Clinical Innovations Introduces New Circumcision Device 2Health News:First and Only Weaning Product Based on 100% Non-Allergenic Amino-Acids Specifically Designed for Children With Cows' Milk Protein Allergy and Multiple Food Protein Intolerance 2Health News:First and Only Weaning Product Based on 100% Non-Allergenic Amino-Acids Specifically Designed for Children With Cows' Milk Protein Allergy and Multiple Food Protein Intolerance 3Health News:Public Call for Participation on National Board of Certification for Medical Interpreters 2Health News:Public Call for Participation on National Board of Certification for Medical Interpreters 3Health News:Apollo Health Street Collaborates with Client to Develop a CCHIT-Certified 08 Ambulatory EMR 2Health News:MDS Reports Second Quarter 2009 Financial Results 2Health News:MDS Reports Second Quarter 2009 Financial Results 3Health News:MDS Reports Second Quarter 2009 Financial Results 4Health News:MDS Reports Second Quarter 2009 Financial Results 5Health News:MDS Reports Second Quarter 2009 Financial Results 6Health News:MDS Reports Second Quarter 2009 Financial Results 7Health News:MDS Reports Second Quarter 2009 Financial Results 8Health News:MDS Reports Second Quarter 2009 Financial Results 9Health News:MDS Reports Second Quarter 2009 Financial Results 10Health News:MDS Reports Second Quarter 2009 Financial Results 11Health News:MDS Reports Second Quarter 2009 Financial Results 12Health News:MDS Reports Second Quarter 2009 Financial Results 13Health News:MDS Reports Second Quarter 2009 Financial Results 14Health News:MDS Reports Second Quarter 2009 Financial Results 15Health News:MDS Reports Second Quarter 2009 Financial Results 16Health News:MDS Reports Second Quarter 2009 Financial Results 17Health News:MDS Reports Second Quarter 2009 Financial Results 18Health News:MDS Reports Second Quarter 2009 Financial Results 19
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... of acute low back pain, they want ... restores functional mobility by providing powerful compression ... sizes that correspond directly to men's or ... reduce inventory requirements while simplifying the fitting ...
... effective immobilization of the cervical and upper ... that makes it well tolerated by patients. ... going from a stand-alone cervical collar, to ... a four-post orthosis. For these reasons, the ...
... laborious custom fabrication was required to produce ... and modifications in response to patient complaints ... evolved from two years of development and ... This orthosis can be quickly adjusted to ...
Medicine Products: